LicianPro

EKSO stock

Ekso Bionics Holdings Inc (EKSO) earnings · last reported Mar 31, 2026

Next report

EKSO has not announced its next report date and there is not enough history to project one.

Earnings move

Last 6 measured reports
Options price in
—
No upcoming report date.
Average move after earnings
±14.4%
Absolute close-to-close move, 6 reports

Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.

Latest result

Mar 31, 2026

EPSGAAP

−$2.04

vs −$0.23 est. −787.0%

Miss

GAAP diluted EPS, SEC 10-Q

Revenue

$2.14M

vs $4.55M est. −52.9%

Miss

As filed with the SEC

EPS actuals are checked against the SEC filing and the company’s earnings press release (8-K EX-99.1). A company that reports only GAAP EPS is graded on its SEC diluted EPS; one that reports adjusted EPS is graded on the provider’s adjusted figure when the release confirms it. A figure that matches neither is shown as unverified, with no beat or miss. Revenue actuals come from the SEC filing of the same quarter where we have it.

Beat / miss history

Last 4 reported quarters
  • Missed EPS 5 quarters in a row
  • Beat EPS in 0 of 4
Apr 29, 2024: EPS −$0.20 vs est. −$0.16Apr ’24Jul 28, 2025: EPS −$1.24 vs est. −$0.08Jul ’25Oct 28, 2025: EPS −$0.54 vs est. −$0.09Oct ’25Mar 31, 2026: EPS −$2.04 vs est. −$0.23Mar ’26
Actual EPS (beat) Actual EPS (miss) Consensus
  • Mar 31, 2026Miss
    EPS −$2.04GAAP vs −$0.23 −787.0%Rev $2.14M vs $4.55M −52.9%
  • Oct 28, 2025Miss
    EPS −$0.54GAAP vs −$0.09 −535.3%Rev $4.23M vs $4.16M +1.7%
  • Jul 28, 2025Miss
    EPS −$1.24GAAP vs −$0.08 −1450.0%Rev $2.06M vs $4.31M −52.3%
  • Apr 29, 2024Miss
    EPS −$0.20GAAP vs −$0.16 −25.0%Rev $3.76M vs $4.99M −24.7%

Earnings documents

Mar 31, 2026 report

No earnings 8-K (item 2.02) is stored for this report yet. All EKSO filings: SEC filings.

Documents link to SEC EDGAR. Lician does not publish earnings-call transcripts.

EKSO stock after earnings

  • Average move after earnings: ±14.4% over the last 6 measured reports.

Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Earnings move details.

These earnings events as JSON? API free 100/day
EKSO reported quarters (10-Q, GAAP diluted EPS)
QuarterRevenueEPSYoY
Q1 FY27$41.48M−$0.29—
Q3 FY26$4.23M−$0.54+2.4%
Q2 FY26$2.06M−$1.24−58.4%
Q1 FY25$3.38M−$0.12−10.1%

Ekso Bionics Holdings Inc (EKSO) is a medical instruments & supplies company listed on NASDAQ.

Latest reported EKSO revenue for 2026-05-31 was $71.6M. Net income was -$50.3M. Revenue was down 15.1% from 2025-05-31 to 2026-05-31. EKSO currently screens at market cap $42.0M.

When the next EKSO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was down 15.1% from 2025-05-31 to 2026-05-31. An earnings headline that ignores that move is noise.

Not investment advice. Full EKSO research stays on the stock page; the tape stays on the quote page.

EKSO earnings FAQ

Did EKSO beat earnings estimates last quarter?

No. On Mar 31, 2026 Ekso Bionics Holdings Inc (EKSO) reported adjusted EPS of −$2.04 against a −$0.23 consensus (−787.0%), a miss. It reported revenue $2.14M vs $4.55M est. (−52.9%).

How does EKSO stock move after earnings?

Over its last 6 measured reports, EKSO moved an average of ±14.4% (absolute close-to-close move) after earnings.

How often does EKSO beat EPS estimates?

Ekso Bionics Holdings Inc (EKSO) beat the EPS consensus in 0 of its last 5 reported quarters. Revenue beat the consensus in 1 of the last 4 quarters with an estimate on file.

What are EKSO's latest revenue and net income?

Latest cached Ekso Bionics Holdings Inc (EKSO) revenue for May 31, 2026 was $71.6M. Net income was -$50.3M. Statements: https://lician.com/financials/ekso

What is EKSO's latest diluted EPS?

Latest cached Ekso Bionics Holdings Inc (EKSO) diluted EPS for May 31, 2026 was -$0.36.

What period does the latest EKSO earnings print cover?

The latest cached Ekso Bionics Holdings Inc (EKSO) earnings print covers May 31, 2026. The prior cached period on this page is May 31, 2025.

How did EKSO revenue change from the prior cached period?

Cached Ekso Bionics Holdings Inc (EKSO) revenue was down 15.1% from $84.4M (May 31, 2025) to $71.6M (May 31, 2026). Statements: https://lician.com/financials/ekso

Where are EKSO earnings listed?

Cached earnings facts for Ekso Bionics Holdings Inc (EKSO) are listed at https://lician.com/earnings/ekso. Statements: https://lician.com/financials/ekso

Not investment advice.

Full EKSO analysis